Abstract: The slow kinetics and low efficiency of reprogramming methods to generate human induced pluripotent stem cells (iPSCs) impose major limitations on their utility in biomedical applications. Here we describe a chemical approach that dramatically improves (>200 fold) the efficiency of iPSC generation from human fibroblasts, within seven days of treatment. This will provide a basis for developing safer, more efficient, non-viral methods for reprogramming human somatic cells.

Abstract: Provided are organometallic compounds comprising a ligand which is at least a two-dentate ligand which comprises at least one 5-membered nitrogen containing heterocyclic ring, the nitrogen of which is bonded to the central metal atom. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a first ligand LA of Formula I?, or Formula I*: In Formula I? or Formula I*, all the variables are defined herein; and LA is coordinated to a metal M. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: The slow kinetics and low efficiency of reprogramming methods to generate human induced pluripotent stem cells (iPSCs) impose major limitations on their utility in biomedical applications. Here we describe a chemical approach that dramatically improves (>200 fold) the efficiency of iPSC generation from human fibroblasts, within seven days of treatment. This will provide a basis for developing safer, more efficient, non-viral methods for reprogramming human somatic cells.

Abstract: Compounds that are organic radicals that can have a dual function. The compounds can be fluorescent emitters that emit in the near-IR. The compounds can also facilitate reverse intersystem crossing (RISC) to convert triplet excitons in an OLED to singlet excited states to maximize utilization of generated excitons in the OLED and approach 100% internal quantum efficiency.

Abstract: The present invention includes novel polycyclic alkyl amino carbenes as ligands for metal complexes. These compounds may be useful as emitter materials for phosphorescent electroluminescent devices.

Abstract: Compounds that are organic radicals that can have a dual function. The compounds can be fluorescent emitters that emit in the near-IR. The compounds can also facilitate reverse intersystem crossing (RISC) to convert triplet excitons in an OLED to singlet excited states to maximize utilization of generated excitons in the OLED and approach 100% internal quantum efficiency.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, each of X1 to X8 is C or N; is a single bond or a double bond; K is a direct bond or a linking group; RA, RB, and RC are each hydrogen or a General Substituent; LA is coordinated to a metal M, having an atomic weight of at least 40; any two substituents may be joined or fused to form a ring; and (i) two RA substituents are joined to form a ring fused to ring A, (ii) two RB substituents are joined to form a ring fused to ring B, or (iii) both condition (i) and condition (ii). Formulations, OLEDs, and consumer products containing the same are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, moiety A is a fused polycyclic ring system; moiety B is a monocyclic ring or a fused polycyclic system; ring C is a 5-membered ring; ring D is a 6-membered ring; Y is N, B, or P; each of Z1 to Z4 is C or N; X1 is CR1 or N; each of K1 and K2 is a direct bond or a linker; each R1, R2, R?, R?, RA, and RB is hydrogen or a General Substituent defined herein; and LA is joined to a metal M by the dashed lines. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, In Formula I, moieties A, B, C, and D are each independently a monocyclic ring or a polycyclic fused ring system; each of Z1, Z2, and X1 to X7 is independently C or N; K is selected from a direct bond and a linker; each R?, R?, RA, RB, RC, and RD is hydrogen or a General Substituent defined herein; any two substituents may be joined or fused to form a ring; LA is joined to a metal M that has an atomic mass of at least 40; M may be coordinated to other ligands; and LA may be joined with other ligands. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are neutral Pt or Pd compounds comprising a tridentate and a monodentate ligand, wherein the tridentate ligand comprises at least three 5- or 6-membered rings. Also provided are formulations comprising these neutral Pt or Pd compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these neutral Pt or Pd compounds.

Abstract: Provided are organometallic complexes including 5-membered heterocyclic rings. The compounds include a ligand LA having a structure of Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: The present invention includes novel polycyclic alkyl amino carbenes as ligands for metal complexes. These compounds may be useful as emitter materials for phosphorescent electroluminescent devices.

Abstract: A compound of Formula I wherein Y is selected from the group consisting of NAr, O, S, and Se; Ar is an optionally substituted aryl or optionally substituted heteroaryl; and Z1 to Z8 are independently selected from C or N, wherein at least one of Z2 or Z3 is C, and at least one of Z6 or Z7 is C. R is selected from the group consisting of deuterium, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof; or optionally R can join with Ar to from a ring; and with the provisios that R is not N-methyl-benzimidazole, and the compound is not compound A.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: Provided are compounds of Formula Ir(LA)x(LC)y wherein: ligand LA has Formula I? ?and ligand LC has Formula II?

Abstract: A compound including a ligand LA of Formula I, where C1 and C2 are carbon atoms and a moiety of Formula II, is bonded to one of C1 and C2 by the two dashed lines in Formula II is provided. The variables in Formulae I and II are as defined in the present disclosure.

Abstract: A compound of Formula I having isoindoline moiety is disclosed. Their unique configuration of the fused rings enable the compound to exhibit phosphorescent emission in red color region to near infrared region and are useful as emitter materials in organic electroluminescence device.

Abstract: Provided are compounds of Formula Ir(LA)x(LC)y, wherein: ligand LA has Formula I? and ligand LC has Formula II?

Abstract: A compound having a first ligand LA of Formula I, is provided. In Formula I, Z is C or N; at least one of X1 to X5 is N, and the remainder are C; if X1 is N, then X5 is C; K is selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); each R?, R?, RA and RB is a hydrogen or a General Substituent; LA is coordinated to a metal M; and Ring A coordinates to M through a metal carbene bond. Formulations, OLEDs, and consumer products containing the compound are also provided.